Related Experiment Video
Updated: Feb 7, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without
Gennaro Giustino1, Lisandro D Colantonio2, Todd M Brown3
1Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Insights
Patients with diabetes mellitus (DM) face higher cardiovascular disease (CVD) risks post-acute myocardial infarction (AMI). Most patients on low/moderate-intensity statins after AMI do not switch to high-intensity statins, regardless of DM status, leaving residual CVD risk.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Patients with diabetes mellitus (DM) have an elevated risk of cardiovascular disease (CVD) events, particularly after an acute myocardial infarction (AMI).
- High-intensity statin therapy is proven to reduce CVD risk in patients post-AMI, including those with DM.
Purpose of the Study:
- To determine the proportion of Medicare beneficiaries aged 66-75 who transitioned to high-intensity statins after an AMI hospitalization.
- To compare statin titration rates between patients with and without DM.
Main Methods:
- Retrospective analysis of Medicare beneficiaries (66-75 years) hospitalized for AMI between 2014-2015.
- Examined statin prescription fills within 365 days prior to and 30 days after AMI hospitalization.
- Compared titration to high-intensity statins (atorvastatin 40/80mg, rosuvastatin 20/40mg) between patients with and without DM.
Main Results:
- Only 37.7% of patients with DM and 44.4% without DM initiated high-intensity statins post-AMI.
- No significant difference in the risk ratio for titrating to high-intensity statins was observed between patients with and without DM (RR 1.01).
- Among those initially on lower-intensity statins, a small percentage (7.5% with DM, 9.2% without DM) escalated to high-intensity statins within 182 days post-AMI.
Conclusions:
- A majority of patients, irrespective of diabetes status, do not escalate to high-intensity statins after AMI when initially prescribed lower-intensity statins.
- This failure to optimize statin therapy may leave a significant portion of patients, especially those with DM, at increased risk for recurrent CVD events.
Background:
Patients with diabetes mellitus (DM) have a high risk for cardiovascular disease (CVD) events after an acute myocardial infarction (AMI). High-intensity statins reduce CVD risk following AMI among patients with and without DM.
Methods:
We determined the proportion of Medicare beneficiaries 66 to 75 years of age taking a low/moderate-intensity statin with (n = 6718) and without (n = 6414) DM who titrated to a high-intensity statin dosage (i.e., atorvastatin 40 or 80 mg, or rosuvastatin 20 or 40 mg) following an AMI hospitalization in 2014-2015. All patients had a pharmacy claim for a statin fill within 365 days prior to, and within 30 days after their AMI hospitalization. We excluded beneficiaries without Medicare fee-for-service coverage including pharmacy benefits during the study period and those with a pharmacy claim for a high-intensity statin prior to their AMI.
Results:
The first statin fill following hospital discharge was for a high-intensity dosage among 37.7% and 44.4% of patients with and without DM, respectively. After multivariable adjustment, the risk ratio (RR) for titrating to a high-intensity statin comparing patients with versus without DM was 1.01 (95% CI 0.96, 1.06). Among patients whose first statin fill post-AMI was for a low/moderate-intensity dosage, 7.5% of those with DM titrated to a high-intensity statin within 182 days, compared with 9.2% of those without DM (multivariable-adjusted RR 0.90 [95% CI 0.75, 1.08]).
Conclusions:
Most patients taking a low/moderate-intensity statin were not titrated to a high-intensity dosage following AMI irrespective of their diabetes status, potentially leaving substantial residual risk for recurrent CVD events.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Titration of a Polyprotic Acid
Acid-Base Titration Curves
For a titration carried out for 25.00 mL of...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Titration Calculations: Weak Acid - Strong Base
For the titration of 25.00 mL of 0.100 M CH3CO2H with 0.100 M NaOH, the reaction can be represented as:

